# About GHK-Cu Order: An Independent Reading of the Literature | GHK-Cu Order

> GHK-Cu Order is an independent editorial project that summarizes the peer-reviewed copper-tripeptide literature. Not a clinic, not a vendor — a metrics-first reading of the published GHK-Cu record.

An independent editorial project that reads the published GHK-Cu literature as a measured pipeline — what the studies found, and where the data stops.

## What this site is

GHK-Cu Order is an independent editorial project that publishes summaries of the peer-reviewed research literature on GHK-Cu, the copper-tripeptide also labeled Copper Tripeptide-1. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site reads that science as a pipeline — copper coordination, the signaling layer, matrix synthesis, the genome-wide readout — because GHK-Cu's mechanism is unusually sequential, and a step-by-step reading keeps the strong findings visible and the gaps honest. Every quantitative claim on the site maps to a numbered study on the [references](/references) page.

## What "Order" means here

The word "Order" in the domain name is editorial framing, not a purchase prompt. It refers to the orderly, sequenced, metrics-on-a-dashboard register the site uses — the literature put into numbered, measured order, read top to bottom. We do not take orders, sell GHK-Cu, or point readers to any vendor.

The distinction matters for a compound like this one. Topical Copper Tripeptide-1 is a legal cosmetic ingredient with a long safety record, but there is no FDA- or EMA-approved therapeutic GHK-Cu product by any route, and injectable or systemic use is unapproved and research-only [4]. The site describes what studies measured in specific species and models; it never recommends a human dose, and it surfaces the copper peptide side effects and cautions as plainly as the benefits.

## How we read the evidence

Three editorial rules govern the writing. First, lead with the measured finding and attribute after — the collagen dose-response, the procollagen comparison, the hair-count deltas are stated, then sourced [1][4][7]. Second, mark the drop-off: where the data thins (no validated human pharmacokinetics, thin controlled-human evidence, single-investigator provenance for much of the gene-expression and anti-aging literature), the site names it [3][4]. Third, keep the GHK-versus-GHK-Cu distinction drawn, since copper coordination is required for most documented activity [2]. The result is a digest meant to be trustworthy rather than promotional.

---

The GHK-Cu copper-tripeptide literature charted as one pipeline — the strong steps logged green, the missing human pharmacokinetics marked as the amber drop-off, and no clinic or vendor on either side of the funnel.